Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Nov 2025 for COLLEGIUM PHARMACEUTICAL, INC, €213k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
John A. Fallon: trading record in brief
This profile gathers the share dealings of John A. Fallon across 2 companies, led by Collegium Pharmaceutical, Inc and Insulet Corp. In total, 7 filings cover trades dated from 20 May 2021 to 12 November 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 14 November 2025 with an option exercise (€213k) in Collegium Pharmaceutical, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John A. Fallon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
15,000 shares@ US$16.49100.0% of flowCommon StockSEC:0001560152-25-000004:0
9,791 shares0Common StockSEC:0001062993-25-009810:0
7,693 shares0Common StockSEC:0001062993-24-010539:0
9,792 shares0Common StockSEC:0001062993-23-011816:0
14,035 shares0Common StockSEC:0001062993-22-013301:0
2,235 shares@ US$28.87100.0% of flowCommon StockSEC:0001127602-21-018010:0
9,941 shares0Common StockSEC:0001192482-21-000457:0
7 of 7 declarations
